PCVX
Vaxcyte, Inc.
Company overview
- Market capitalization
- $8.67B
- Employees
- 507
- Latest publication
- 2026-09-29
About Vaxcyte, Inc.
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 312,779,000USD | 242,060,000USD | 209,933,000USD | 194,179,000USD | 148,134,000USD | 476,644,000USD | 116,936,000USD | 131,507,000USD |
| Total Operating Expenses | 345,850,000USD | 279,272,000USD | 242,380,000USD | 226,219,000USD | 180,793,000USD | 569,546,000USD | 139,924,000USD | 152,981,000USD |
| Net Income | -320,622,000USD | -246,507,000USD | -212,830,000USD | -166,573,000USD | -140,718,000USD | -463,927,000USD | -103,124,000USD | -128,703,000USD |
| Total Revenue | — | 0USD | — | — | — | — | — | 0USD |
| Cost Of Revenue | — | -4,989,000USD | — | — | — | — | — | 3,478,000USD |
| Gross Profit | — | 4,989,000USD | — | — | — | — | — | -3,478,000USD |
| Selling General Administrative | — | 32,223,000USD | — | — | — | — | — | 21,474,000USD |
| Unclassified Operating Expenses | — | 4,989,000USD | — | — | — | — | — | — |
| Operating Income | — | -274,283,000USD | — | — | — | — | — | -152,981,000USD |
| Interest Income | — | 26,451,000USD | — | — | — | — | — | 23,813,000USD |
| Net Interest Income | — | 26,451,000USD | — | — | — | — | — | 23,813,000USD |
| Income Before Tax | — | -246,507,000USD | — | — | — | — | — | -128,703,000USD |
| Net Income From Continuing Ops | — | -246,507,000USD | — | — | — | — | — | -128,703,000USD |
| Ebit | — | -246,507,000USD | — | — | — | — | — | -128,703,000USD |
| Ebitda | — | -234,574,000USD | — | — | — | — | — | -125,225,000USD |
| Depreciation And Amortization | — | 11,933,000USD | — | — | — | — | — | 3,478,000USD |
| Reconciled Depreciation | — | 9,800,000USD | — | — | — | — | — | 3,478,000USD |
| Total Other Income Expense Net | — | 27,776,000USD | — | — | — | — | — | 24,278,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20212021-12-31 · USD | FY 20172017-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | — |
| Research Development | 794,306,000USD | 476,644,000USD | 78,411,000USD | 12,785,000USD |
| Selling General Administrative | 129,369,000USD | 92,902,000USD | 25,259,000USD | 5,048,000USD |
| Total Operating Expenses | 923,675,000USD | 569,546,000USD | 103,670,000USD | 17,402,000USD |
| Operating Income | -923,675,000USD | -569,546,000USD | -103,670,000USD | -17,833,000USD |
| Interest Income | 119,718,000USD | 109,994,000USD | 344,000USD | 155,000USD |
| Net Interest Income | 119,718,000USD | 109,994,000USD | 337,000USD | — |
| Income Before Tax | -766,628,000USD | -463,927,000USD | -100,077,000USD | -17,238,000USD |
| Net Income | -766,628,000USD | -463,927,000USD | -100,077,000USD | -17,238,000USD |
| Net Income From Continuing Ops | -766,628,000USD | -463,927,000USD | -100,077,000USD | — |
| Ebit | -766,628,000USD | -463,927,000USD | -100,070,000USD | -17,833,000USD |
| Ebitda | -741,768,000USD | -448,082,000USD | -96,613,000USD | -17,208,000USD |
| Depreciation And Amortization | 24,860,000USD | 15,845,000USD | 3,457,000USD | 625,000USD |
| Reconciled Depreciation | 24,860,000USD | 15,845,000USD | 3,457,000USD | — |
| Total Other Income Expense Net | 157,047,000USD | 105,619,000USD | 3,593,000USD | 595,000USD |
| Cost Of Revenue | — | 15,845,000USD | 1,800,000USD | — |
| Gross Profit | — | -15,845,000USD | -1,800,000USD | — |
| Interest Expense | — | 0USD | 7,000USD | 0USD |
| Income Tax Expense | — | — | 7,000USD | — |
| Non Operating Income Net Other | — | — | 3,593,000USD | — |
| Net Income Applicable To Common Shares | — | — | -100,077,000USD | -17,238,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,138,154,000USD | 3,348,308,000USD | 3,002,717,000USD | 3,171,600,000USD | 3,305,363,000USD | 3,378,103,000USD | 3,511,318,000USD | 3,559,746,000USD |
| Cash And Equivalents | 183,190,000USD | 260,843,000USD | 173,959,000USD | 281,080,000USD | 306,744,000USD | 346,850,000USD | 387,878,000USD | 1,050,189,000USD |
| Cash And Short Term Investments | 1,486,838,000USD | 1,737,178,000USD | 1,560,959,000USD | 1,711,320,000USD | 1,661,427,000USD | 1,671,731,000USD | 1,747,208,000USD | 2,180,465,000USD |
| Short Term Investments | 1,303,648,000USD | 1,476,335,000USD | 1,387,000,000USD | 1,430,240,000USD | 1,354,683,000USD | 1,324,881,000USD | 1,359,330,000USD | 1,130,276,000USD |
| Long Term Investments | 1,020,896,000USD | 1,004,017,000USD | 881,664,000USD | 959,256,000USD | 1,165,091,000USD | 1,279,031,000USD | 1,387,510,000USD | 1,092,574,000USD |
| Total Current Assets | 1,552,668,000USD | 1,813,488,000USD | 1,627,361,000USD | 1,767,167,000USD | 1,715,775,000USD | 1,716,563,000USD | 1,787,985,000USD | 2,213,865,000USD |
| Other Current Assets | 65,830,000USD | 76,310,000USD | 1,594,000USD | 55,847,000USD | 54,348,000USD | 44,832,000USD | 4,456,000USD | 3,443,000USD |
| Other Non Current Assets | 192,557,000USD | 155,539,000USD | 118,847,000USD | 106,708,000USD | 95,263,000USD | 76,276,000USD | 64,359,000USD | 60,046,000USD |
| Total Liabilities | 380,212,000USD | 352,294,000USD | 317,207,000USD | 278,718,000USD | 234,029,000USD | 178,077,000USD | 205,499,000USD | 142,112,000USD |
| Total Current Liabilities | 271,277,000USD | 242,082,000USD | 205,750,000USD | 200,046,000USD | 154,486,000USD | 96,996,000USD | 140,180,000USD | 123,790,000USD |
| Other Current Liabilities | 24,728,000USD | 30,247,000USD | 31,068,000USD | 24,592,000USD | 32,214,000USD | 26,042,000USD | 29,123,000USD | 30,753,000USD |
| Total Stockholder Equity | 2,757,942,000USD | 2,996,014,000USD | 2,685,510,000USD | 2,892,882,000USD | 3,071,334,000USD | 3,200,026,000USD | 3,305,819,000USD | 3,417,634,000USD |
| Total Equity Including Noncontrolling Interest | 2,757,942,000USD | 2,996,014,000USD | 2,685,510,000USD | 2,892,882,000USD | 3,071,334,000USD | 3,200,026,000USD | 3,305,819,000USD | 3,417,634,000USD |
| Property Plant Equipment Net | 370,568,000USD | 373,798,000USD | 373,379,000USD | 337,001,000USD | 327,915,000USD | 304,914,000USD | 270,147,000USD | 191,943,000USD |
| Accounts Payable | 100,919,000USD | 63,060,000USD | 70,904,000USD | 48,962,000USD | 31,414,000USD | 20,514,000USD | 48,452,000USD | 18,219,000USD |
| Short Term Debt | 6,510,000USD | 6,085,000USD | 6,124,000USD | 5,771,000USD | 6,302,000USD | 6,128,000USD | 5,891,000USD | 9,637,000USD |
| Common Stock | 148,000USD | 147,000USD | 134,000USD | 133,000USD | 133,000USD | 132,000USD | 128,000USD | 127,000USD |
| Retained Earnings | -2,759,871,000USD | -2,475,569,000USD | -2,154,947,000USD | -1,908,440,000USD | -1,695,610,000USD | -1,529,037,000USD | -1,388,319,000USD | -1,251,239,000USD |
| Accumulated Other Comprehensive Income | -7,546,000USD | -6,834,000USD | 1,587,000USD | 856,000USD | -1,887,000USD | -322,000USD | -3,873,000USD | 139,000USD |
| Other Non Current Liabilities | — | — | 100,000USD | — | — | — | 100,000USD | — |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,002,717,000USD | 3,511,318,000USD | 1,407,917,000USD | 1,006,178,000USD | 324,337,000USD | 392,826,000USD | 65,698,000USD | 70,802,000USD |
| Cash And Equivalents | 173,959,000USD | 387,878,000USD | 397,451,000USD | 834,657,000USD | 68,985,000USD | 386,200,000USD | — | — |
| Cash And Short Term Investments | 1,560,959,000USD | 1,747,208,000USD | 1,080,227,000USD | 931,376,000USD | 245,970,000USD | — | 58,976,000USD | 66,090,000USD |
| Short Term Investments | 1,387,000,000USD | 1,359,330,000USD | 682,776,000USD | 96,719,000USD | 176,985,000USD | — | — | — |
| Long Term Investments | 881,664,000USD | 1,387,510,000USD | 162,675,000USD | 26,549,000USD | 27,117,000USD | — | — | — |
| Total Current Assets | 1,627,361,000USD | 1,787,985,000USD | 1,095,954,000USD | 942,555,000USD | 256,348,000USD | 389,004,000USD | 61,723,000USD | 66,668,000USD |
| Other Current Assets | 1,594,000USD | 4,456,000USD | 2,105,000USD | 11,179,000USD | 10,378,000USD | 2,804,000USD | 2,747,000USD | 578,000USD |
| Other Non Current Assets | 118,847,000USD | 64,359,000USD | 37,562,000USD | 4,555,000USD | 4,089,000USD | 550,000USD | — | — |
| Total Liabilities | 317,207,000USD | 205,499,000USD | 167,449,000USD | 52,565,000USD | 40,319,000USD | 46,983,000USD | — | — |
| Total Current Liabilities | 205,750,000USD | 140,180,000USD | 145,338,000USD | 40,525,000USD | 28,716,000USD | 46,861,000USD | 11,052,000USD | 6,713,000USD |
| Other Current Liabilities | 31,068,000USD | 29,123,000USD | 59,815,000USD | 15,375,000USD | 8,787,000USD | 3,766,000USD | — | — |
| Other Non Current Liabilities | 100,000USD | 100,000USD | 0USD | 9,000USD | 96,000USD | 112,000USD | — | — |
| Total Stockholder Equity | 2,685,510,000USD | 3,305,819,000USD | 1,240,468,000USD | 953,613,000USD | 284,018,000USD | 345,843,000USD | -106,373,000USD | -57,728,000USD |
| Total Equity Including Noncontrolling Interest | 2,685,510,000USD | 3,305,819,000USD | 1,240,468,000USD | 953,613,000USD | 284,018,000USD | 345,843,000USD | — | — |
| Property Plant Equipment Net | 373,379,000USD | 270,147,000USD | 110,623,000USD | 31,648,000USD | 35,912,000USD | 3,272,000USD | 3,391,000USD | 3,411,000USD |
| Accounts Payable | 70,904,000USD | 48,452,000USD | 14,587,000USD | 9,795,000USD | 6,758,000USD | 29,785,000USD | 3,376,000USD | 2,830,000USD |
| Short Term Debt | 6,124,000USD | 5,891,000USD | 7,113,000USD | 5,910,000USD | 5,276,000USD | — | 161,000USD | 297,000USD |
| Common Stock | 134,000USD | 128,000USD | 98,000USD | 82,000USD | 56,000USD | 54,000USD | 7,000USD | 6,000USD |
| Retained Earnings | -2,154,947,000USD | -1,388,319,000USD | -924,392,000USD | -522,126,000USD | -298,641,000USD | -198,564,000USD | -109,347,000USD | -59,073,000USD |
| Accumulated Other Comprehensive Income | 1,587,000USD | -3,873,000USD | 179,000USD | -361,000USD | -241,000USD | — | -160,310,000USD | -1,751,000USD |
| Total Liab | — | — | — | — | — | — | 172,071,000USD | 128,530,000USD |
| Other Current Liab | — | — | — | — | — | — | 7,515,000USD | 3,883,000USD |
| Capital Stock | — | — | — | — | — | — | 7,000USD | 6,000USD |
| Other Liab | — | — | — | — | — | — | 259,000USD | 199,000USD |
| Other Assets | — | — | — | — | — | — | 584,000USD | 723,000USD |
| Cash | — | — | — | — | — | — | 58,976,000USD | 66,090,000USD |
| Net Debt | — | — | — | — | — | — | -58,815,000USD | -65,632,000USD |
| Short Long Term Debt Total | — | — | — | — | — | — | 611,000USD | 3,944,000USD |
| Long Term Debt | — | — | — | — | — | — | 450,000USD | 3,647,000USD |
| Net Receivables | — | — | — | — | — | — | 200,000USD | — |
| Inventory | — | — | — | — | — | — | -200,000USD | — |
| Property Plant Equipment Gross | — | — | — | — | — | — | 6,373,000USD | — |
| Common Stock Shares Outstanding | — | — | — | — | — | — | 48,857,820shares | 25,598,640shares |
| Non Current Assets Total | — | — | — | — | — | — | 3,975,000USD | 4,134,000USD |
| Non Current Liabilities Total | — | — | — | — | — | — | 161,019,000USD | 121,817,000USD |
| Non Current Liabilities Other | — | — | — | — | — | — | 242,000USD | 3,351,000USD |
| Non Currrent Assets Other | — | — | — | — | — | — | 584,000USD | 723,000USD |
| Net Working Capital | — | — | — | — | — | — | 50,671,000USD | 59,955,000USD |
| Net Tangible Assets | — | — | — | — | — | — | -106,373,000USD | -57,728,000USD |
| Unclassified Non Current Liabilities | — | — | — | — | — | — | 160,068,000USD | 114,620,000USD |
| Unclassified Equity | — | — | — | — | — | — | 163,270,000USD | 3,084,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | -297,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 3,002,000USD | 2,947,000USD | 9,800,000USD | 5,197,000USD | 4,989,000USD | 2,956,000USD | 4,785,000USD | 4,491,000USD |
| Stock Based Compensation | 41,241,000USD | 37,964,000USD | 35,997,000USD | 35,306,000USD | 36,927,000USD | 30,615,000USD | 24,370,000USD | 21,265,000USD |
| Change To Liabilities | 37,751,000USD | -15,840,000USD | — | — | — | -33,556,000USD | — | — |
| Change In Working Capital | -7,723,000USD | -25,888,000USD | 3,655,000USD | 32,075,000USD | 33,691,000USD | -37,216,000USD | -2,485,000USD | 29,216,000USD |
| Operating Cash Flow | -232,471,000USD | -280,625,000USD | — | — | — | -166,274,000USD | — | — |
| Capital Expenditures | -4,319,000USD | -2,107,000USD | 5,568,000USD | -12,046,000USD | 19,516,000USD | -5,424,000USD | -30,027,000USD | -38,080,000USD |
| Net Investments | 152,293,000USD | -218,616,000USD | — | — | — | 150,068,000USD | — | — |
| Unclassified Investing Cash Flow | -255,000USD | -12,687,000USD | — | -121,170,000USD | 9,755,000USD | -21,327,000USD | 30,027,000USD | 115,200,000USD |
| Investing Cash Flow | 147,719,000USD | -233,410,000USD | — | — | — | 123,317,000USD | — | — |
| Common Stock Issuance | 7,761,000USD | 9,032,000USD | — | — | — | — | — | — |
| Net Common Stock Issuance | -2,060,000USD | -9,295,000USD | — | — | — | -5,290,000USD | — | — |
| Unclassified Financing Cash Flow | 0USD | 601,846,000USD | -3,541,000USD | — | 3,235,000USD | 6,049,000USD | — | 1,507,110,000USD |
| Financing Cash Flow | 5,701,000USD | 601,583,000USD | — | — | — | 759,000USD | — | — |
| Effect Of Forex Changes On Cash | 1,397,000USD | -664,000USD | — | — | — | 1,172,000USD | — | — |
| Change In Cash | -77,654,000USD | 86,884,000USD | -107,123,000USD | -25,515,000USD | -40,106,000USD | -41,026,000USD | -662,312,000USD | 531,734,000USD |
| End Cash Flow | 184,655,000USD | 262,309,000USD | — | — | — | 348,169,000USD | — | — |
| Net Income | — | — | -246,507,000USD | -212,830,000USD | -166,573,000USD | — | -137,080,000USD | -103,124,000USD |
| Other Non Cash Items | — | — | -27,777,000USD | -3,053,000USD | -30,200,000USD | — | -991,000USD | -12,556,000USD |
| Total Cash From Operating Activities | — | — | -224,832,000USD | -143,305,000USD | -121,166,000USD | — | -111,401,000USD | -60,708,000USD |
| Free Cash Flow | — | — | -219,264,000USD | -155,351,000USD | -101,650,000USD | — | -141,428,000USD | -98,788,000USD |
| Investments | — | — | 123,546,000USD | 121,170,000USD | 77,742,000USD | — | -557,168,000USD | -917,019,000USD |
| Total Cashflows From Investing Activities | — | — | 115,125,000USD | 121,170,000USD | 77,742,000USD | — | -557,168,000USD | -917,019,000USD |
| Total Cash From Financing Activities | — | — | 2,408,000USD | -3,671,000USD | 2,518,000USD | — | 4,907,000USD | 1,515,037,000USD |
| Issuance Of Capital Stock | — | — | 0USD | 0USD | 0USD | — | 8,000USD | 1,512,636,000USD |
| Begin Period Cash Flow | — | — | 282,548,000USD | 308,063,000USD | 348,169,000USD | — | 1,051,507,000USD | 519,773,000USD |
| End Period Cash Flow | — | — | 175,425,000USD | 282,548,000USD | 308,063,000USD | — | 389,195,000USD | 1,051,507,000USD |
| Other Cashflows From Investing Activities | — | — | -13,989,000USD | 133,216,000USD | -29,271,000USD | — | — | -77,120,000USD |
| Other Cashflows From Financing Activities | — | — | 5,949,000USD | -3,977,000USD | -717,000USD | — | 4,899,000USD | 2,401,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | — | 5,526,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD | Q3 20222022-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 5,949,000USD | 8,899,000USD | 5,835,000USD | 4,139,000USD | 2,351,000USD | 2,268,000USD | 1,462,000USD | 1,875,000USD |
| Stock Based Compensation | 79,205,000USD | 102,848,000USD | 67,542,000USD | 60,452,000USD | 39,187,000USD | 35,412,000USD | 22,192,000USD | 16,641,000USD |
| Change To Liabilities | 21,911,000USD | -3,090,000USD | -21,032,000USD | -23,059,000USD | -40,005,000USD | 4,235,000USD | 6,278,000USD | 4,902,000USD |
| Change In Working Capital | -33,611,000USD | -37,359,000USD | -44,835,000USD | -21,307,000USD | -22,127,000USD | 8,540,000USD | 436,000USD | 1,743,000USD |
| Operating Cash Flow | -513,096,000USD | -430,745,000USD | -287,440,000USD | -341,226,000USD | -280,518,000USD | -167,980,000USD | -110,432,000USD | -105,376,000USD |
| Capital Expenditures | -6,426,000USD | -11,059,000USD | -7,235,000USD | -18,406,000USD | -13,459,000USD | -10,808,000USD | -3,469,000USD | -4,701,000USD |
| Net Investments | -66,323,000USD | 370,781,000USD | 237,565,000USD | -1,359,366,000USD | -480,427,000USD | -748,577,000USD | -778,196,000USD | 115,231,000USD |
| Unclassified Investing Cash Flow | -12,942,000USD | -37,493,000USD | -29,271,000USD | -70,726,000USD | -37,593,000USD | — | — | 7,000USD |
| Investing Cash Flow | -85,691,000USD | 322,229,000USD | 201,059,000USD | -1,448,498,000USD | -531,479,000USD | -759,385,000USD | -781,665,000USD | 110,537,000USD |
| Common Stock Issuance | 16,793,000USD | 9,590,000USD | 9,284,000USD | 1,655,000USD | 1,655,000USD | 1,017,000USD | 1,017,000USD | 550,000USD |
| Net Common Stock Issuance | -11,355,000USD | -9,984,000USD | -6,007,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | 601,846,000USD | — | — | 2,441,946,000USD | 926,909,000USD | 636,061,000USD | 587,511,000USD | 204,364,000USD |
| Financing Cash Flow | 607,284,000USD | -394,000USD | 3,277,000USD | 2,443,601,000USD | 928,564,000USD | 637,078,000USD | 588,528,000USD | 204,914,000USD |
| Effect Of Forex Changes On Cash | 733,000USD | 2,263,000USD | 1,972,000USD | -924,000USD | 4,652,000USD | 996,000USD | -55,000USD | -659,000USD |
| Change In Cash | 9,230,000USD | -106,647,000USD | -81,132,000USD | 652,953,000USD | 121,219,000USD | -289,291,000USD | -303,624,000USD | 209,416,000USD |
| End Cash Flow | 184,655,000USD | 282,548,000USD | 308,063,000USD | 1,051,507,000USD | 519,773,000USD | 546,237,000USD | 531,904,000USD | 279,272,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 16,396,000USD | 7,003,000USD | 3,156,000USD | 2,577,000USD | 1,800,000USD | 1,405,000USD | 1,232,000USD | 1,037,000USD |
| Stock Based Compensation | 138,845,000USD | 84,822,000USD | 48,760,000USD | 23,650,000USD | 10,729,000USD | 5,434,000USD | 1,185,000USD | 749,000USD |
| Change To Liabilities | 25,873,000USD | -1,069,000USD | 47,520,000USD | 10,067,000USD | -7,839,000USD | 28,309,000USD | 868,000USD | 1,266,000USD |
| Change In Working Capital | -36,780,000USD | 2,246,000USD | -3,912,000USD | 2,864,000USD | -23,378,000USD | 25,969,000USD | 3,908,000USD | 1,895,000USD |
| Operating Cash Flow | -655,577,000USD | -452,627,000USD | -296,790,000USD | -170,597,000USD | -121,393,000USD | -46,628,000USD | — | — |
| Capital Expenditures | -13,713,000USD | -22,427,000USD | -16,062,000USD | -5,848,000USD | -6,555,000USD | -1,155,000USD | -1,195,000USD | -1,774,000USD |
| Net Investments | 494,327,000USD | -1,886,507,000USD | -705,434,000USD | 80,426,000USD | -205,779,000USD | — | — | — |
| Unclassified Investing Cash Flow | -43,260,000USD | -96,732,000USD | -51,815,000USD | 7,000USD | 26,000USD | 50,000USD | 1,195,000USD | 1,773,000USD |
| Investing Cash Flow | 437,354,000USD | -2,005,666,000USD | -773,311,000USD | 74,585,000USD | -212,308,000USD | -1,105,000USD | — | — |
| Common Stock Issuance | 13,005,000USD | 27,144,000USD | 2,038,000USD | 1,033,000USD | 888,000USD | 374,000USD | — | — |
| Net Common Stock Issuance | -10,991,000USD | -14,292,000USD | — | — | — | — | — | — |
| Financing Cash Flow | 2,014,000USD | 2,448,508,000USD | 639,813,000USD | 861,547,000USD | 17,796,000USD | 374,870,000USD | — | — |
| Effect Of Forex Changes On Cash | 2,439,000USD | 426,000USD | -6,686,000USD | 137,000USD | -439,000USD | 87,000USD | — | — |
| Change In Cash | -213,770,000USD | -9,359,000USD | -436,974,000USD | 765,672,000USD | -316,344,000USD | 327,224,000USD | -7,114,000USD | 29,951,000USD |
| End Cash Flow | 175,425,000USD | 389,195,000USD | 398,554,000USD | 835,528,000USD | 69,856,000USD | 386,200,000USD | — | — |
| Unclassified Financing Cash Flow | — | 2,435,656,000USD | 637,775,000USD | 860,514,000USD | 16,908,000USD | 374,496,000USD | -42,942,000USD | -62,473,000USD |
| Net Income | — | — | — | — | — | — | -50,274,000USD | -29,485,000USD |
| Other Non Cash Items | — | — | — | — | — | — | -3,196,000USD | -4,713,000USD |
| Change To Account Receivables | — | — | — | — | — | — | 868,000USD | 1,266,000USD |
| Change To Inventory | — | — | — | — | — | — | 2,870,000USD | -1,187,000USD |
| Total Cash From Operating Activities | — | — | — | — | — | — | -47,145,000USD | -30,466,000USD |
| Free Cash Flow | — | — | — | — | — | — | -48,340,000USD | -32,240,000USD |
| Investments | — | — | — | — | — | — | -1,195,000USD | -1,773,000USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | — | -1,195,000USD | -1,773,000USD |
| Net Borrowings | — | — | — | — | — | — | -278,000USD | -283,000USD |
| Total Cash From Financing Activities | — | — | — | — | — | — | 41,567,000USD | 62,190,000USD |
| Sale Purchase Of Stock | — | — | — | — | — | — | 42,942,000USD | 62,473,000USD |
| Issuance Of Capital Stock | — | — | — | — | — | — | 42,500,000USD | 62,345,000USD |
| Begin Period Cash Flow | — | — | — | — | — | — | 66,090,000USD | 36,139,000USD |
| End Period Cash Flow | — | — | — | — | — | — | 58,976,000USD | 66,090,000USD |
| Other Cashflows From Financing Activities | — | — | — | — | — | — | 41,845,000USD | 62,473,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 1,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.